| J06BB06 |
J06BB06 Rubella Immunoglobulin |
| J06BB07 |
J06BB07 Vaccinia Immunoglobulin |
| J06BB08 |
J06BB08 Staphylococcus Immunoglobulin |
| J06BB09 |
J06BB09 Cytomegalovirus Immunoglobulin |
| J06BB10 |
J06BB10 Diphtheria Immunoglobulin |
| J06BB11 |
J06BB11 Hepatitis A Immunoglobulin |
| J06BB12 |
J06BB12 Encephalitis, Tick Borne Immunoglobulin |
| J06BB13 |
J06BB13 Pertussis Immunoglobulin |
| J06BB14 |
J06BB14 Measles Immunoglobulin |
| J06BB15 |
J06BB15 Mumps Immunoglobulin |
| J06BB16 |
J06BB16 palivizumab |
| J06BB17 |
J06BB17 Motavizumab |
| J06BB18 |
J06BB18 Raxibacumab |
| J06BB19 |
J06BB19 Anthrax Immunoglobulin |
| J06BB21 |
J06BB21 Bezlotoxumab |
| J06BB22 |
J06BB22 Obiltoxaximab |
| J06BB30 |
J06BB30 Combinations |
| J06BC |
J06BC Other Immunoglobulins |
| J06BC01 |
J06BC01 Nebacumab |
| J06BD |
J06BD Antiviral monoclonal antibodies |
| J06BD01 |
J06BD01 Palivizumab |
| J06BD02 |
J06BD02 Motavizumab |
| J06BD03 |
J06BD03 Tixagevimab and cilgavimab |
| J06BD04 |
J06BD04 Ansuvimab |
| J06BD05 |
J06BD05 Sotrovimab |
| J06BD06 |
J06BD06 Regdanvimab |
| J06BD07 |
J06BD07 Casirivimab and imdevimab |
| J06BD08 |
J06BD08 Nirsevimab |
| J06BD09 |
J06BD09 Sipavibart |
| J06BD10 |
J06BD10 Clesrovimab |